YD Bio Limited Ordinary Shares

Healthcare

NASDAQ:YDES · NASDAQ Global Select

Market Cap $231.62M Beta -0.18 P/E (TTM) -2.2
$3.27 +0.62%

+$0.02 today

52W Low $2.88High $25.00

Vol 0.01M · Avg 0.02M

EPS (TTM)-$1.51
Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-72.84%

Period High

$23.11

Period Low

$2.94

Latest

$3.27

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
DA

Day One Biopharmaceuticals, Inc.

DAWN

$2.22B

Tyra Biosciences, Inc.

Tyra Biosciences, Inc.

NASDAQ:TYRA

$1.61B

Vir Biotechnology, Inc.

Vir Biotechnology, Inc.

NASDAQ:VIR

$1.45B

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

$1.19B

BT

BlackRock Technology and Private Equity Term Trust

BTX

$1.05B

Theravance Biopharma, Inc.

Theravance Biopharma, Inc.

NASDAQ:TBPH

$857.84M

Geron Corporation

Geron Corporation

NASDAQ:GERN

$737.75M

Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

$722.58M

Prime Medicine, Inc.

Prime Medicine, Inc.

NASDAQ:PRME

$501.21M

LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc.

NASDAQ:LENZ

$212.27M

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.